{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:05Z","timestamp":1761100985492},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.3816\/clm.2005.n.024","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:42Z","timestamp":1221095442000},"page":"31-36","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Follow-up High-Dose Chemotherapy (Drug-Only Program) Followed by Autologous Stem Cell Transplantation for Aggressive Non-Hodgkin's Lymphomas"],"prefix":"10.3816","volume":"6","author":[{"given":"Noriko","family":"Usui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Asai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Dobashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Otubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Okawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hagino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2005.n.024_bib1","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.1999.17.10.3128","article-title":"Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma","volume":"17","author":"Friedberg","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood-2002-04-1261","article-title":"Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study","volume":"101","author":"Metayer","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.024_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2003.07.113","article-title":"Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients","volume":"21","author":"Armitage","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib4","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non- Hodgkin's lymphomas: summary and description of a working formulation for clinical usage","volume":"49","author":"The Non-Hodgkin's Lymphoma Pathologic Classification Project","year":"1982","journal-title":"Cancer"},{"key":"10.3816\/CLM.2005.n.024_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.1999.17.1.423","article-title":"International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury","volume":"17","author":"Shipp","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib6","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2002.09.138","article-title":"Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease","volume":"20","author":"Vose","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib7","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.024_bib8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","article-title":"Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma","volume":"38","author":"McKelvey","year":"1976","journal-title":"Cancer"},{"key":"10.3816\/CLM.2005.n.024_bib9","first-page":"39a","article-title":"Role of oral administration of etoposide in the combination chemotherapy (ABCVEP-I & II) for aggressive histology lymphoma","volume":"18","author":"Usui","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib10","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.1995.13.8.1995","article-title":"Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy","volume":"13","author":"Wilson","year":"1995","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.3816\/CLM.2005.n.024_bib11","first-page":"360b","article-title":"ACNU-ETOP-CBDCA-CPM followed by autologous hematopoietic stem cell transplantation in refractory aggressive non-Hodgkin's lymphoma","volume":"92","author":"Asai","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.024_bib12","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.3816\/CLM.2005.n.024_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trial requiring prolonged observation of each patient. II analysis and examples","volume":"35","author":"Petp","year":"1977","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2005.n.024_bib15","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.1994.12.12.2543","article-title":"Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediategrade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte","volume":"12","author":"Haioun","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib16","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","article-title":"High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma","volume":"336","author":"Gianni","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.024_bib17","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.1998.16.8.2796","article-title":"VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non- Hodgkin's lymphoma: results of a prospective randomized trial by the Non- Hodgkin's Lymphoma Cooperative Study Group","volume":"16","author":"Santini","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib18","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1200\/JCO.1997.15.3.1131","article-title":"Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte","volume":"15","author":"Haioun","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.2003.01.117","article-title":"Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial","volume":"21","author":"Martelli","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib20","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.V96.7.2399","article-title":"High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis","volume":"96","author":"Kewalramani","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.024_bib21","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.024_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2141.2001.02955.x","article-title":"Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma","volume":"114","author":"Cortelazzo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.024_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1200\/JCO.1998.16.1.48","article-title":"Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non- Hodgkin's lymphoma: value of augmented preparative regimens\u2014a Southwest Oncology Group trial","volume":"16","author":"Stiff","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-12-3837","article-title":"Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma","volume":"102","author":"Hamlin","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.024_bib25","first-page":"14","article-title":"Treatment of non-Hodgkin's lymphoma","volume":"328","author":"Armitage","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.024_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.024_bib27","doi-asserted-by":"crossref","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","article-title":"MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma","volume":"102","author":"Klimo","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2005.n.024_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1991.9.1.25","article-title":"Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial [published erratum in J Clin Oncol 1991; 9:710]","volume":"9","author":"Longo","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib29","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V73.7.1749.bloodjournal7371749","article-title":"Bone marrow transplantation in the treatment of patients with lymphoma","volume":"73","author":"Armitage","year":"1989","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.024_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy- sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2005.n.024_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.2001.19.2.406","article-title":"Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry","volume":"19","author":"Vose","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.024_bib32","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/JCO.2000.18.16.3025","article-title":"Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 Protocol\u2014a Groupe d'Etude des Lymphomes de l'Adulte Study","volume":"18","author":"Haioun","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:09:47Z","timestamp":1588918187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511701142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1526965511701142"],"URL":"https:\/\/doi.org\/10.3816\/clm.2005.n.024","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}